ConductScience.org, home

Paper9623976

A role for carbohydrates in immune evasion in AIDS.

Reitter JN and 2 others. Nat Med, 1998. Cited by 486 papers, by iCite.

Cite this record

ConductScience Library. A role for carbohydrates in immune evasion in AIDS. Papers, record 9623976. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9623976

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A role for carbohydrates in immune evasion in AIDS.
PubMed
Journal
Nat Med
PubMed
Year
1998
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
486
iCite
Relative citation ratio, by iCite
10.5
iCite
Revised in PubMed
2019-09-14
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Reitter JNJ N
2Means RER E
3Desrosiers RCR C

Source PubMed

Download CSV of authors

Topics20

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CarbohydratesMajor topic
ImmunizationMajor topic
Macaca mulattaMajor topic
Membrane GlycoproteinsMajor topic
Simian Acquired Immunodeficiency SyndromeMajor topic
Viral Envelope ProteinsMajor topic
Amino Acid Sequence
Animals
Antibodies, Viral
Antibody Formation
Binding Sites
Genetic Variation
HIV Envelope Protein gp120
Molecular Sequence Data
Mutation
Neutralization Tests
Sequence Analysis
Sequence Homology, Amino Acid
Simian Immunodeficiency Virus
Viral Load

Source PubMed

Download CSV of topics

Grants4

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
AI 35365NIAID NIH HHSUnited StatesPubMedPubMed
RR00168NCRR NIH HHSUnited StatesP06RR000168PubMed and NIHNIH RePORTER
P40RR000168NIHNIH RePORTER
P51RR000168NIHNIH RePORTER

Download CSV of grants

Cited by277

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 486 citations.

PMIDTitleJournalYearIn PapersSource
42655632HIV-1 Env Heterogeneity: Cleavage, Trafficking, and Antigenic Consequences for Virions and Infected Cells.Viruses2026https://conductscience.org/library/papers/42655632PubMed
42060718Broad neutralization of influenza B hemagglutinin antibodies via receptor mimicry and glycan engagement.Proc Natl Acad Sci U S A2026https://conductscience.org/library/papers/42060718PubMed
41926428Defining the impact of Getah virus envelope protein glycosylation site mutations on viral replication, host adaptation, virulence, and immune evasion.PLoS Pathog2026https://conductscience.org/library/papers/41926428PubMed
41796803Decoding the glycan shield: Immune recognition and response to the HIV-1 envelope trimer.J Biol Chem2026https://conductscience.org/library/papers/41796803PubMed
38805549Macrophage- and CD4+ T cell-derived SIV differ in glycosylation, infectivity and neutralization sensitivity.PLoS Pathog2024https://conductscience.org/library/papers/38805549PubMed
37112819A Novel Insertion in the Hepatitis B Virus Surface Protein Leading to Hyperglycosylation Causes Diagnostic and Immune Escape.Viruses2023https://conductscience.org/library/papers/37112819PubMed
36068229Molecular insights into antibody-mediated protection against the prototypic simian immunodeficiency virus.Nat Commun2022https://conductscience.org/library/papers/36068229PubMed
35540760Insights into the molecular mechanism underlying CD4-dependency and neutralization sensitivity of HIV-1: a comparative molecular dynamics study on gp120s from isolates with different phenotypes.RSC Adv2018https://conductscience.org/library/papers/35540760PubMed
34806305Structure-guided envelope trimer design in HIV-1 vaccine development: a narrative review.J Int AIDS Soc2021https://conductscience.org/library/papers/34806305PubMed
34649433Immunogenicity Evaluation of N-Glycans Recognized by HIV Broadly Neutralizing Antibodies.ACS Chem Biol2021https://conductscience.org/library/papers/34649433PubMed
34579215Plant-Expressed Receptor Binding Domain of the SARS-CoV-2 Spike Protein Elicits Humoral Immunity in Mice.Vaccines (Basel)2021https://conductscience.org/library/papers/34579215PubMed
34063241Complement Proteins as Soluble Pattern Recognition Receptors for Pathogenic Viruses.Viruses2021https://conductscience.org/library/papers/34063241PubMed
33801906Immunogenicity of HIV-1-Based Virus-Like Particles with Increased Incorporation and Stability of Membrane-Bound Env.Vaccines (Basel)2021https://conductscience.org/library/papers/33801906PubMed
33007365Biomedical nanoparticle design: What we can learn from viruses.J Control Release2021https://conductscience.org/library/papers/33007365PubMed
32841299Cells producing residual viremia during antiretroviral treatment appear to contribute to rebound viremia following interruption of treatment.PLoS Pathog2020https://conductscience.org/library/papers/32841299PubMed
32762760Longitudinal analysis of subtype C envelope tropism for memory CD4+ T cell subsets over the first 3 years of untreated HIV-1 infection.Retrovirology2020https://conductscience.org/library/papers/32762760PubMed
32518179Key Positions of HIV-1 Env and Signatures of Vaccine Efficacy Show Gradual Reduction of Population Founder Effects at the Clade and Regional Levels.mBio2020https://conductscience.org/library/papers/32518179PubMed
32512942N-Glycosylation and N-Glycan Processing in HBV Biology and Pathogenesis.Cells2020https://conductscience.org/library/papers/32512942PubMed
32403312Elicitation of Cluster A and Co-Receptor Binding Site Antibodies are Required to Eliminate HIV-1 Infected Cells.Microorganisms2020https://conductscience.org/library/papers/32403312PubMed
32340497Targeting the N332-supersite of the HIV-1 envelope for vaccine design.Expert Opin Ther Targets2020https://conductscience.org/library/papers/32340497PubMed

See all 277 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/9623976

GET https://conductscience.org/api/papers/v1/9623976/cited_by?page=2